Plus, news about Oruka Therapeutics, Centessa, Takeda, Innate Pharma and Liquidia: GSK’s mRNA flu vaccine succeeds against both strains in Phase 2: The pharma company ...

Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...

Merck and Kelun-Biotech revealed Phase 3 breast cancer data for the lead antibody-drug conjugate in their potentially $12 billion partnership. In a Phase 3 trial for locally recurrent or ...

April 29, 2024 05:53 PM EDT Updated 06:48 PM ...

To help meet the heightened demand for its injectable products, Eli Lilly is acquiring a facility from Nexus Pharmaceuticals, with production anticipated to start at the end of next year ...

March 11, 2024 04:54 AM EDT Updated March 12, 06:55 PM ...

House Re­pub­li­cans take is­sue with DO­J's han­dling of Mod­er­na's Covid vac­cine patents ...

ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. The Chicago-based venture capital firm has ...

December 15, 2023 06:33 AM EST Updated 09:01 AM ...

Small molecule biotech Totus Medicines has closed a $66 million Series B to carry its PI3Kα inhibitor through Phase Ia and has named Nassim Usman as its new president and ...

Hand­ful of biotechs ex­pect­ed to IPO this fall, but many are stuck in ‘hold­ing pat­tern’ un­til 2024 ...

Bristol Myers Squibb plans to let go of 108 employees in New Jersey, citing an “evolving” business model. The layoffs, set to go into effect Nov. 2, will affect employees ...